Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 4/2009

01-04-2009 | Original

Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model

Authors: Rosanna Di Paola, Marta Menegazzi, Emanuela Mazzon, Tiziana Genovese, Concetta Crisafulli, Martina Dal Bosco, Zhenzhen Zou, Hisanori Suzuki, Salvatore Cuzzocrea

Published in: Intensive Care Medicine | Issue 4/2009

Login to get access

Abstract

Purpose

This study investigated the effects of glycyrrhizin, a potent antioxidant, on tissue injury caused by ischemia/reperfusion (I/R) of the gut.

Methods

I/R injury of the intestine was caused by clamping both the superior mesenteric artery and the celiac trunk for 45 min followed by release of the clamp allowing reperfusion for 1 or 6 h.

Results

Administration of glycyrrhizin, significantly reduced the (a) fall of mean arterial blood pressure, (b) mortality rate, (c) myeloperoxidase (MPO) activity, (d) production of pro-inflammatory cytokines [tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β)], (e) histological evidence of gut injury, (f) immunoreactivity of nitrotyrosine, (g) poly ADP-ribose (PAR) formation, (h) the expression of ICAM-1 and P-selectin, (i) activation of nuclear factor-κB (NF-κB) and (j) signal transducer and activator transcription-3 (STAT-3) induced by splanchnic artery occlusion–reperfusion shock.

Conclusions

This study demonstrates that glycyrrhizin exerts multiple protective effects in splanchnic artery occlusion–reperfusion shock.
Literature
1.
2.
del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM (1991) Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22:1276–1283PubMed
3.
Murota S, Fujita H, Wakabayashi Y, Morita I (1996) Cell adhesion molecule mediates endothelial cell injury caused by activated neutrophils. Keio J Med 45:207–211 discussion 211–202PubMed
4.
Weiss SJ (1989) Tissue destruction by neutrophils. New Engl J Med 320:365–376PubMed
5.
Li C, Jackson RM (2002) Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol 282:C227–C241
6.
Cerqueira NF, Hussni CA, Yoshida WB (2005) Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras 20:336–343PubMed
7.
Bjork J, Hedqvist P, Arfors KE (1982) Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes. Inflammation 6:189–200PubMedCrossRef
8.
Nosal’ova V, Navarova J, Mihalova D, Sotnikova R (2007) Mesenteric ischemia/reperfusion-induced intestinal and vascular damage: effect of stobadine. Methods Find Exp Clin Pharmacol 29:39–45PubMedCrossRef
9.
Jaeschke H (2006) Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol 290:G1083–G1088
10.
Spanos CP, Papaconstantinou P, Spanos P, Karamouzis M, Lekkas G, Papaconstantinou C (2007) The effect of l-arginine and aprotinin on intestinal ischemia-reperfusion injury. J Gastrointest Surg 11:247–255PubMedCrossRef
11.
Yung LM, Leung FP, Yao X, Chen ZY, Huang Y (2006) Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets 6:1–19PubMed
12.
Valentino M, Governa M, Marchiseppe I, Visona I (1991) Effects of lead on polymorphonuclear leukocyte (PMN) functions in occupationally exposed workers. Arch Toxicol 65:685–688PubMedCrossRef
13.
Cuzzocrea S, Riley DP, Caputi AP, Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53:135–159PubMed
14.
McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159–163PubMed
15.
Baldus S, Mullerleile K, Chumley P, Steven D, Rudolph V, Lund GK, Staude HJ, Stork A, Koster R, Kahler J, Weiss C, Munzel T, Meinertz T, Freeman BA, Heitzer T (2006) Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy. Free Radic Biol Med 41:1282–1288PubMedCrossRef
16.
Kang SM, Lim S, Song H, Chang W, Lee S, Bae SM, Chung JH, Lee H, Kim HG, Yoon DH, Kim TW, Jang Y, Sung JM, Chung NS, Hwang KC (2006) Allopurinol modulates reactive oxygen species generation and Ca2+overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes. Eur J Pharmacol 535:212–219PubMedCrossRef
17.
Akamatsu H, Komura J, Asada Y, Niwa Y (1991) Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Med 57:119–121PubMedCrossRef
18.
Hosseinzadeh H, Nassiri Asl M, Parvardeh S (2005) The effects of carbenoxolone, a semisynthetic derivative of glycyrrhizinic acid, on peripheral and central ischemia-reperfusion injuries in the skeletal muscle and hippocampus of rats. Phytomedicine 12:632–637PubMedCrossRef
19.
Subramanian S, Bowyer MW, Egan JC, Knolmayer TJ (1999) Attenuation of renal ischemia-reperfusion injury with selectin inhibition in a rabbit model. Am J Surg 178:573–576PubMedCrossRef
20.
Nagai T, Egashira T, Yamanaka Y, Kohno M (1991) The protective effect of glycyrrhizin against injury of the liver caused by ischemia-reperfusion. Arch Environ Contam Toxicol 20:432–436PubMedCrossRef
21.
Kilgore KS, Tanhehco EJ, Park JL, Naylor KB, Anderson MB, Lucchesi BR (1998) Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics. J Pharmacol Exp Ther 284:427–435PubMed
22.
Kang DG, Sohn EJ, Mun YJ, Woo WH, Lee HS (2003) Glycyrrhizin ameliorates renal function defects in the early-phase of ischemia-induced acute renal failure. Phytother Res 17:947–951PubMedCrossRef
23.
Zingarelli B, Yang Z, Hake PW, Denenberg A, Wong HR (2001) Absence of endogenous interleukin 10 enhances early stress response during post-ischaemic injury in mice intestine. Gut 48:610–622PubMedCrossRef
24.
Hayward R, Lefer AM (1998) Time course of endothelial-neutrophil interaction in splanchnic artery ischemia-reperfusion. Am J Physiol 275:H2080–H2086PubMed
25.
van Rossum TG, Vulto AG, Hop WC, Schalm SW (1999) Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection. Clin Ther 21:2080–2090PubMedCrossRef
26.
Mullane KM, Kraemer R, Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157–167PubMedCrossRef
27.
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef
28.
Menegazzi M, Di Paola R, Mazzon E, Genovese T, Crisafulli C, Dal Bosco M, Zou Z, Suzuki H, Cuzzocrea S (2008) Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. Pharmacol Res 58:22–31PubMedCrossRef
29.
Squadrito F, Sturniolo R, Altavilla D, Campo GM, Trimarchi GR, Scuri R, Caputi AP (1989) Effects of fructose 1, 6-diphosphate on splanchnic artery occlusion shock in the rat. Resuscitation 18:299–307PubMedCrossRef
30.
Cuzzocrea S, Mazzon E, Esposito E, Muia C, Abdelrahman M, Di Paola R, Crisafulli C, Bramanti P, Thiemermann C (2007) Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut. Intensive Care Med 33:880–893PubMedCrossRef
31.
Ruszymah BH, Nabishah BM, Aminuddin S, Khalid BA (1995) Effects of glycyrrhizic acid on right atrial pressure and pulmonary vasculature in rats. Clin Exp Hypertens 17:575–591PubMedCrossRef
32.
Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM, Venkatachalam MA (1998) Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 17:3401–3415PubMedCrossRef
33.
Semenza GL (2000) Cellular and molecular dissection of reperfusion injury: ROS within and without. Circ Res 86:117–118PubMed
34.
Rackova L, Jancinova V, Petrikova M, Drabikova K, Nosal R, Stefek M, Kostalova D, Pronayova N, Kovacova M (2007) Mechanism of anti-inflammatory action of liquorice extract and glycyrrhizin. Nat Prod Res 21:1234–1241PubMed
35.
Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393–397PubMedCrossRef
36.
Giovannelli L, Cozzi A, Guarnieri I, Dolara P, Moroni F (2002) Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors. J Cereb Blood Flow Metab 22:697–704PubMedCrossRef
37.
Mandir AS, Poitras MF, Berliner AR, Herring WJ, Guastella DB, Feldman A, Poirier GG, Wang ZQ, Dawson TM, Dawson VL (2000) NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase. J Neurosci 20:8005–8011PubMed
38.
Klass AA (1953) Acute mesenteric arterial occlusion: restoration of blood flow by embolectomy. J Int Coll Surg 20:687–694PubMed
39.
Klausner JM, Anner H, Paterson IS, Kobzik L, Valeri CR, Shepro D, Hechtman HB (1988) Lower torso ischemia-induced lung injury is leukocyte dependent. Ann Surg 208:761–767PubMedCrossRef
40.
Welbourn CR, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB (1991) Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 78:651–655PubMedCrossRef
41.
Butcher EC (1992) Leukocyte-endothelial cell adhesion as an active, multi-step process: a combinatorial mechanism for specificity and diversity in leukocyte targeting. Adv Exp Med Biol 323:181–194PubMed
42.
Kwon HM, Choi YJ, Choi JS, Kang SW, Bae JY, Kang IJ, Jun JG, Lee SS, Lim SS, Kang YH (2007) Blockade of cytokine-induced endothelial cell adhesion molecule expression by licorice isoliquiritigenin through NF-kappaB signal disruption. Exp Biol Med (Maywood) 232:235–245
43.
Welbourn R, Goldman G, O’Riordain M, Lindsay TF, Paterson IS, Kobzik L, Valeri CR, Shepro D, Hechtman HB (1991) Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol 70:2645–2649PubMed
44.
Mangino MJ, Anderson CB, Murphy MK, Brunt E, Turk J (1989) Mucosal arachidonate metabolism and intestinal ischemia–reperfusion injury. Am J Physiol 257:G299–G307PubMed
45.
Mozes T, Braquet P, Filep J (1989) Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am J Physiol 257:R872–R877PubMed
46.
Souza DG, Teixeira MM (2005) The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion. Mem Inst Oswaldo Cruz 100(Suppl 1):59–66PubMed
47.
Blackwell TS, Christman JW (1997) The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 17:3–9PubMed
48.
Grotz M, Regel G, Schratt HE, Seekamp A, Pape HC, Tscherne H (1996) Intestinal cytokine liberation after intestinal ischemia in the rat-studies in the Ussing chamber system. Z Gastroenterol 34:783–790PubMed
49.
Bean P (2002) The use of alternative medicine in the treatment of hepatitis C. Am Clin Lab 21:19–21
50.
McCormick J, Barry SP, Sivarajah A, Stefanutti G, Townsend PA, Lawrence KM, Eaton S, Knight RA, Thiemermann C, Latchman DS, Stephanou A (2006) Free radical scavenging inhibits STAT phosphorylation following in vivo ischemia/reperfusion injury. FASEB J 20:2115–2117PubMedCrossRef
Metadata
Title
Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model
Authors
Rosanna Di Paola
Marta Menegazzi
Emanuela Mazzon
Tiziana Genovese
Concetta Crisafulli
Martina Dal Bosco
Zhenzhen Zou
Hisanori Suzuki
Salvatore Cuzzocrea
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 4/2009
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-008-1334-y

Other articles of this Issue 4/2009

Intensive Care Medicine 4/2009 Go to the issue

Brief Report

Submission of clinical studies to ethics committees or clinical trials registers: the authors’ point of view

Editorial

Hippocampus: a future target for sepsis treatment!

Mini Series: Basic research-related topics in ICM

Mini-series: II. Clinical aspects. Clinically relevant CYP450-mediated drug interactions in the ICU

Brief Report

A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis

Acknowledgement to Reviewers

Acknowledgement to reviewers

Brief Report

A simple aspiration test to determine the accuracy of oesophageal placement of fine-bore feeding tubes